Page last updated: 2024-08-22

pimozide and Prostatic Neoplasms, Castration-Resistant

pimozide has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hongo, H; Kosaka, T; Oya, M; Suzuki, Y1

Other Studies

1 other study(ies) available for pimozide and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screening.
    Prostate cancer and prostatic diseases, 2023, Volume: 26, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Early Detection of Cancer; Humans; Male; Mice; Pimozide; Prostatic Neoplasms, Castration-Resistant; Taxoids

2023